Blavatnik Len's Form 4 filing
Day One Biopharmaceuticals, Inc. (DAWN) · filed Jun 21, 2022
- Accession no.
- 0001209191-22-038431
- Filed
- Jun 21, 2022, 4:37 PM ET
- Trade date
- Jun 17, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $18.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blavatnik LenCIK 0001326628 | Other: Affiliate of 10% Owner |
| Access Industries Holdings LLCCIK 0001391297 | Other: Affiliate of 10% Owner |
| Access Industries Management, LLCCIK 0001508226 | Other: Affiliate of 10% Owner |
| AI Day1 LLCCIK 0001863302 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2022 | Common Stock | PPurchaseAcquired | +1,200,000 | $15.00 | +$18,000,000 | 10,684,638 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.